Egyptian International Pharmaceutical Industries Company (EGX: PHAR)

Market Cap	6.75B
Revenue (ttm)	7.00B
Net Income (ttm)	1.16B
Shares Out	148.76M
EPS (ttm)	7.82
PE Ratio	5.80
Forward PE	6.79
Dividend	1.00 (2.19%)
Ex-Dividend Date	Apr 28, 2024

Volume	223,857
Average Volume	212,325
Open	45.67
Previous Close	45.67
Day's Range	44.91 - 46.25
52-Week Range	32.23 - 54.70
Beta	0.39
RSI	48.40
Earnings Date	Feb 25, 2025

About EGX: PHAR

Egyptian International Pharmaceutical Industries Company manufactures and distributes medicines, and medical and veterinary preparations in Egypt and internationally. It produces various dosage forms, such as spansule capsules, soft gelatin capsules, lyophilized products, gels, sprayers, and effervescent tablets, as well as antibiotics. The company also provides Covid-19 related protocol medicine, including epicehin, epizithro, cetal, dexamethasone, and cevitil. gyptian International Pharmaceutical Industries Company was incorporated in 1980 an...

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: PHAR

Financial Performance

In 2023, PHAR's revenue was 5.23 billion, an increase of 32.27% compared to the previous year's 3.96 billion. Earnings were 822.32 million, an increase of 27.89%.